Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09VPA
|
||||
Former ID |
DNC004711
|
||||
Drug Name |
4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H12BrN
|
||||
Canonical SMILES |
C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)Br
|
||||
InChI |
1S/C15H12BrN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9+
|
||||
InChIKey |
MNQUPNOEJZVKRD-FMIVXFBMSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527456] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | ||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
SteroidogenesisPW000141:Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.